APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brucellosis Vaccines

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

Selected research

Industry Growth & Trends

Global Brucellosis Vaccines Industry Growth and Trends Forecast to 2032

21 December 2025116 pages

Choose your research edition.

Industry ResearchBrucellosis Vaccines Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Brucellosis Vaccines Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Brucellosis Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brucellosis Vaccines Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Brucellosis Vaccines Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Brucellosis Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Brucellosis Vaccines market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Brucellosis Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Brucellosis Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Brucellosis Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Brucellosis Vaccines Market by Company

Jinyu

Colorado Serum

Boehringer Ingelheim

Biogenesis-Bago

Vetal Company

CZ Veterinaria

SYVA Laboratorios

Indian Immunologicals

Qilu

Tecnovax

Hester Biosciences

Zoetis

Onderstepoort Biological

Instituto Rosenbusch

Ceva Sante Animale

Calier & Biologicos Laverlam

Biovet

Brucellosis Vaccines Segment by Type

S19 Vaccine

RB51 Vaccine Strain

Brucellosis Vaccines Segment by Application

Cattle

Sheep

Others

Brucellosis Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucellosis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brucellosis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucellosis Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Brucellosis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Brucellosis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of S19 Vaccine Table 2. Major Company of RB51 Vaccine Strain Table 3. Global Brucellosis Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 5. Global Brucellosis Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Brucellosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Brucellosis Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Brucellosis Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 9. Global Brucellosis Vaccines Sales by Type (2027-2032) & (M Doses) Table 10. Global Brucellosis Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Brucellosis Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Brucellosis Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Brucellosis Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 14. North America Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 15. North America Brucellosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 17. Europe Brucellosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 19. Asia-Pacific Brucellosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 21. Latin America Brucellosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 23. Middle East and Africa Brucellosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Brucellosis Vaccines Industry Trends Table 25. Brucellosis Vaccines Industry Drivers Table 26. Brucellosis Vaccines Industry Opportunities and Challenges Table 27. Brucellosis Vaccines Industry Restraints Table 28. Global Brucellosis Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Brucellosis Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Brucellosis Vaccines Sales by Company (2021-2026) & (M Doses) Table 31. Global Brucellosis Vaccines Sales Share by Company (2021-2026) Table 32. Global Brucellosis Vaccines Market Price by Company (2021-2026) & (USD/K Doses) Table 33. Global Brucellosis Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Brucellosis Vaccines Major Company Production Sites and Headquarters Table 35. Global Brucellosis Vaccines Company, Product Type & Application Table 36. Global Brucellosis Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Brucellosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Brucellosis Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Brucellosis Vaccines Sales by Region (2021-2026) & (M Doses) Table 41. Global Brucellosis Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Brucellosis Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Brucellosis Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Brucellosis Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 45. Global Brucellosis Vaccines Sales by Region (2027-2032) & (M Doses) Table 46. Global Brucellosis Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Brucellosis Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Brucellosis Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Brucellosis Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2027-2032) Table 50. Global Brucellosis Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 52. Global Brucellosis Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Brucellosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Brucellosis Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Brucellosis Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 56. Global Brucellosis Vaccines Sales by Application (2027-2032) & (M Doses) Table 57. Global Brucellosis Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Brucellosis Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Brucellosis Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Brucellosis Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 61. North America Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 62. North America Brucellosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 64. Europe Brucellosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 66. Asia-Pacific Brucellosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 68. Latin America Brucellosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 70. Middle East and Africa Brucellosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Jinyu Company Information Table 72. Jinyu Business Overview Table 73. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 74. Jinyu Brucellosis Vaccines Product Portfolio Table 75. Jinyu Recent Development Table 76. Colorado Serum Company Information Table 77. Colorado Serum Business Overview Table 78. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 79. Colorado Serum Brucellosis Vaccines Product Portfolio Table 80. Colorado Serum Recent Development Table 81. Boehringer Ingelheim Company Information Table 82. Boehringer Ingelheim Business Overview Table 83. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 84. Boehringer Ingelheim Brucellosis Vaccines Product Portfolio Table 85. Boehringer Ingelheim Recent Development Table 86. Biogenesis-Bago Company Information Table 87. Biogenesis-Bago Business Overview Table 88. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 89. Biogenesis-Bago Brucellosis Vaccines Product Portfolio Table 90. Biogenesis-Bago Recent Development Table 91. Vetal Company Company Information Table 92. Vetal Company Business Overview Table 93. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 94. Vetal Company Brucellosis Vaccines Product Portfolio Table 95. Vetal Company Recent Development Table 96. CZ Veterinaria Company Information Table 97. CZ Veterinaria Business Overview Table 98. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 99. CZ Veterinaria Brucellosis Vaccines Product Portfolio Table 100. CZ Veterinaria Recent Development Table 101. SYVA Laboratorios Company Information Table 102. SYVA Laboratorios Business Overview Table 103. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 104. SYVA Laboratorios Brucellosis Vaccines Product Portfolio Table 105. SYVA Laboratorios Recent Development Table 106. Indian Immunologicals Company Information Table 107. Indian Immunologicals Business Overview Table 108. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 109. Indian Immunologicals Brucellosis Vaccines Product Portfolio Table 110. Indian Immunologicals Recent Development Table 111. Qilu Company Information Table 112. Qilu Business Overview Table 113. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 114. Qilu Brucellosis Vaccines Product Portfolio Table 115. Qilu Recent Development Table 116. Tecnovax Company Information Table 117. Tecnovax Business Overview Table 118. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 119. Tecnovax Brucellosis Vaccines Product Portfolio Table 120. Tecnovax Recent Development Table 121. Hester Biosciences Company Information Table 122. Hester Biosciences Business Overview Table 123. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 124. Hester Biosciences Brucellosis Vaccines Product Portfolio Table 125. Hester Biosciences Recent Development Table 126. Zoetis Company Information Table 127. Zoetis Business Overview Table 128. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 129. Zoetis Brucellosis Vaccines Product Portfolio Table 130. Zoetis Recent Development Table 131. Onderstepoort Biological Company Information Table 132. Onderstepoort Biological Business Overview Table 133. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 134. Onderstepoort Biological Brucellosis Vaccines Product Portfolio Table 135. Onderstepoort Biological Recent Development Table 136. Instituto Rosenbusch Company Information Table 137. Instituto Rosenbusch Business Overview Table 138. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 139. Instituto Rosenbusch Brucellosis Vaccines Product Portfolio Table 140. Instituto Rosenbusch Recent Development Table 141. Ceva Sante Animale Company Information Table 142. Ceva Sante Animale Business Overview Table 143. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 144. Ceva Sante Animale Brucellosis Vaccines Product Portfolio Table 145. Ceva Sante Animale Recent Development Table 146. Calier & Biologicos Laverlam Company Information Table 147. Calier & Biologicos Laverlam Business Overview Table 148. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 149. Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio Table 150. Calier & Biologicos Laverlam Recent Development Table 151. Biovet Company Information Table 152. Biovet Business Overview Table 153. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 154. Biovet Brucellosis Vaccines Product Portfolio Table 155. Biovet Recent Development Table 156. North America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 157. North America Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 158. North America Brucellosis Vaccines Sales Market Share by Country (2021-2026) Table 159. North America Brucellosis Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 160. North America Brucellosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 161. North America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Brucellosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Brucellosis Vaccines Market Share by Country (2021-2026) Table 164. North America Brucellosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Brucellosis Vaccines Market Share Forecast by Country (2027-2032) Table 166. Europe Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 167. Europe Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 168. Europe Brucellosis Vaccines Sales Market Share by Country (2021-2026) Table 169. Europe Brucellosis Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 170. Europe Brucellosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Brucellosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Brucellosis Vaccines Market Share by Country (2021-2026) Table 174. Europe Brucellosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Brucellosis Vaccines Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 178. Asia-Pacific Brucellosis Vaccines Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Brucellosis Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 180. Asia-Pacific Brucellosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Brucellosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Brucellosis Vaccines Market Share by Country (2021-2026) Table 184. Asia-Pacific Brucellosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Brucellosis Vaccines Market Share Forecast by Country (2027-2032) Table 186. Latin America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 187. Latin America Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 188. Latin America Brucellosis Vaccines Sales Market Share by Country (2021-2026) Table 189. Latin America Brucellosis Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 190. Latin America Brucellosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Brucellosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Brucellosis Vaccines Market Share by Country (2021-2026) Table 194. Latin America Brucellosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Brucellosis Vaccines Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 198. Middle East and Africa Brucellosis Vaccines Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Brucellosis Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 200. Middle East and Africa Brucellosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Brucellosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Brucellosis Vaccines Market Share by Country (2021-2026) Table 204. Middle East and Africa Brucellosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Brucellosis Vaccines Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Brucellosis Vaccines Distributors List Table 209. Brucellosis Vaccines Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Brucellosis Vaccines Image Figure 2. Global Brucellosis Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brucellosis Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Brucellosis Vaccines Sales (2021-2032) & (M Doses) Figure 5. S19 Vaccine Image Figure 6. Global S19 Vaccine Sales YoY Growth (2021-2032) & (M Doses) Figure 7. RB51 Vaccine Strain Image Figure 8. Global RB51 Vaccine Strain Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Global Brucellosis Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Brucellosis Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Brucellosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Brucellosis Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Brucellosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Brucellosis Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Brucellosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Brucellosis Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Brucellosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Brucellosis Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Brucellosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Brucellosis Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Brucellosis Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cattle Image Figure 24. Global Cattle Sales YoY Growth (2021-2032) & (M Doses) Figure 25. Sheep Image Figure 26. Global Sheep Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (M Doses) Figure 29. Global Brucellosis Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Brucellosis Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Brucellosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Brucellosis Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Brucellosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Brucellosis Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Brucellosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Brucellosis Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Brucellosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Brucellosis Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Brucellosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Brucellosis Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Brucellosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 42. North America Brucellosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Brucellosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Brucellosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Brucellosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 46. Europe Brucellosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Brucellosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Brucellosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Brucellosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 50. Asia-Pacific Brucellosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Brucellosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Brucellosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Brucellosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 54. Latin America Brucellosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Brucellosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Brucellosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Brucellosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 58. Middle East and Africa Brucellosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Brucellosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Brucellosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Brucellosis Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Brucellosis Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • S19 Vaccine
  • RB51 Vaccine Strain
Applications
  • Cattle
  • Sheep
  • Others
Companies covered
  • Jinyu
  • Colorado Serum
  • Boehringer Ingelheim
  • Biogenesis-Bago
  • Vetal Company
  • CZ Veterinaria
  • SYVA Laboratorios
  • Indian Immunologicals
  • Qilu
  • Tecnovax
  • Hester Biosciences
  • Zoetis
  • Onderstepoort Biological
  • Instituto Rosenbusch
  • Ceva Sante Animale
  • Calier & Biologicos Laverlam
  • Biovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Brucellosis Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Brucellosis Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Brucellosis Vaccines Market by Type
  6. 1.3.1 S19 Vaccine
  7. 1.3.2 RB51 Vaccine Strain
  8. 1.4 Global Brucellosis Vaccines Market Size by Type
  9. 1.4.1 Global Brucellosis Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Brucellosis Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Brucellosis Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Brucellosis Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Brucellosis Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Brucellosis Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Brucellosis Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Brucellosis Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Brucellosis Vaccines Industry Trends
  2. 2.2 Brucellosis Vaccines Industry Drivers
  3. 2.3 Brucellosis Vaccines Industry Opportunities and Challenges
  4. 2.4 Brucellosis Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Brucellosis Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Brucellosis Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Brucellosis Vaccines Price (2021-2026)
  4. 3.4 Global Brucellosis Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Brucellosis Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Brucellosis Vaccines Company, Product Type & Application
  7. 3.7 Global Brucellosis Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Brucellosis Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Brucellosis Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Brucellosis Vaccines Tier 1, Tier 2, and Tier 3
4 Brucellosis Vaccines Regional Status and Outlook
  1. 4.1 Global Brucellosis Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Brucellosis Vaccines Historic Market Size by Region
  3. 4.2.1 Global Brucellosis Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Brucellosis Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Brucellosis Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Brucellosis Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Brucellosis Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Brucellosis Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Brucellosis Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Brucellosis Vaccines by Application
  1. 5.1 Brucellosis Vaccines Market by Application
  2. 5.1.1 Cattle
  3. 5.1.2 Sheep
  4. 5.1.3 Others
  5. 5.2 Global Brucellosis Vaccines Market Size by Application
  6. 5.2.1 Global Brucellosis Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Brucellosis Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Brucellosis Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Brucellosis Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Brucellosis Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Brucellosis Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Brucellosis Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Brucellosis Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jinyu
  2. 6.1.1 Jinyu Company Information
  3. 6.1.2 Jinyu Business Overview
  4. 6.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jinyu Brucellosis Vaccines Product Portfolio
  6. 6.1.5 Jinyu Recent Developments
  7. 6.2 Colorado Serum
  8. 6.2.1 Colorado Serum Company Information
  9. 6.2.2 Colorado Serum Business Overview
  10. 6.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Colorado Serum Brucellosis Vaccines Product Portfolio
  12. 6.2.5 Colorado Serum Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Brucellosis Vaccines Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 Biogenesis-Bago
  20. 6.4.1 Biogenesis-Bago Company Information
  21. 6.4.2 Biogenesis-Bago Business Overview
  22. 6.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biogenesis-Bago Brucellosis Vaccines Product Portfolio
  24. 6.4.5 Biogenesis-Bago Recent Developments
  25. 6.5 Vetal Company
  26. 6.5.1 Vetal Company Company Information
  27. 6.5.2 Vetal Company Business Overview
  28. 6.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vetal Company Brucellosis Vaccines Product Portfolio
  30. 6.5.5 Vetal Company Recent Developments
  31. 6.6 CZ Veterinaria
  32. 6.6.1 CZ Veterinaria Company Information
  33. 6.6.2 CZ Veterinaria Business Overview
  34. 6.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CZ Veterinaria Brucellosis Vaccines Product Portfolio
  36. 6.6.5 CZ Veterinaria Recent Developments
  37. 6.7 SYVA Laboratorios
  38. 6.7.1 SYVA Laboratorios Company Information
  39. 6.7.2 SYVA Laboratorios Business Overview
  40. 6.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SYVA Laboratorios Brucellosis Vaccines Product Portfolio
  42. 6.7.5 SYVA Laboratorios Recent Developments
  43. 6.8 Indian Immunologicals
  44. 6.8.1 Indian Immunologicals Company Information
  45. 6.8.2 Indian Immunologicals Business Overview
  46. 6.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Indian Immunologicals Brucellosis Vaccines Product Portfolio
  48. 6.8.5 Indian Immunologicals Recent Developments
  49. 6.9 Qilu
  50. 6.9.1 Qilu Company Information
  51. 6.9.2 Qilu Business Overview
  52. 6.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Qilu Brucellosis Vaccines Product Portfolio
  54. 6.9.5 Qilu Recent Developments
  55. 6.10 Tecnovax
  56. 6.10.1 Tecnovax Company Information
  57. 6.10.2 Tecnovax Business Overview
  58. 6.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Tecnovax Brucellosis Vaccines Product Portfolio
  60. 6.10.5 Tecnovax Recent Developments
  61. 6.11 Hester Biosciences
  62. 6.11.1 Hester Biosciences Company Information
  63. 6.11.2 Hester Biosciences Business Overview
  64. 6.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hester Biosciences Brucellosis Vaccines Product Portfolio
  66. 6.11.5 Hester Biosciences Recent Developments
  67. 6.12 Zoetis
  68. 6.12.1 Zoetis Company Information
  69. 6.12.2 Zoetis Business Overview
  70. 6.12.3 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Zoetis Brucellosis Vaccines Product Portfolio
  72. 6.12.5 Zoetis Recent Developments
  73. 6.13 Onderstepoort Biological
  74. 6.13.1 Onderstepoort Biological Company Information
  75. 6.13.2 Onderstepoort Biological Business Overview
  76. 6.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Onderstepoort Biological Brucellosis Vaccines Product Portfolio
  78. 6.13.5 Onderstepoort Biological Recent Developments
  79. 6.14 Instituto Rosenbusch
  80. 6.14.1 Instituto Rosenbusch Company Information
  81. 6.14.2 Instituto Rosenbusch Business Overview
  82. 6.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Instituto Rosenbusch Brucellosis Vaccines Product Portfolio
  84. 6.14.5 Instituto Rosenbusch Recent Developments
  85. 6.15 Ceva Sante Animale
  86. 6.15.1 Ceva Sante Animale Company Information
  87. 6.15.2 Ceva Sante Animale Business Overview
  88. 6.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Ceva Sante Animale Brucellosis Vaccines Product Portfolio
  90. 6.15.5 Ceva Sante Animale Recent Developments
  91. 6.16 Calier & Biologicos Laverlam
  92. 6.16.1 Calier & Biologicos Laverlam Company Information
  93. 6.16.2 Calier & Biologicos Laverlam Business Overview
  94. 6.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio
  96. 6.16.5 Calier & Biologicos Laverlam Recent Developments
  97. 6.17 Biovet
  98. 6.17.1 Biovet Company Information
  99. 6.17.2 Biovet Business Overview
  100. 6.17.3 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Biovet Brucellosis Vaccines Product Portfolio
  102. 6.17.5 Biovet Recent Developments
7 North America by Country
  1. 7.1 North America Brucellosis Vaccines Sales by Country
  2. 7.1.1 North America Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Brucellosis Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Brucellosis Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Brucellosis Vaccines Market Size by Country
  6. 7.2.1 North America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Brucellosis Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Brucellosis Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Brucellosis Vaccines Sales by Country
  2. 8.1.1 Europe Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Brucellosis Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Brucellosis Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Brucellosis Vaccines Market Size by Country
  6. 8.2.1 Europe Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Brucellosis Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Brucellosis Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Brucellosis Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Brucellosis Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Brucellosis Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Brucellosis Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Brucellosis Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Brucellosis Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Brucellosis Vaccines Sales by Country
  2. 10.1.1 South America Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Brucellosis Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Brucellosis Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Brucellosis Vaccines Market Size by Country
  6. 10.2.1 South America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Brucellosis Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Brucellosis Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Brucellosis Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Brucellosis Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Brucellosis Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Brucellosis Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Brucellosis Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Brucellosis Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Brucellosis Vaccines Value Chain Analysis
  2. 12.1.1 Brucellosis Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Brucellosis Vaccines Production Mode & Process
  7. 12.2 Brucellosis Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Brucellosis Vaccines Distributors
  10. 12.2.3 Brucellosis Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst